Bio-Techne (TECH) Change in Cash (2009 - 2026)
Bio-Techne (TECH) posted quarterly Change in Cash of $36.9 million for Q1 2026, up 200.17% year-over-year from $12.3 million in Q1 2025, and up 32.32% quarter-over-quarter from $27.9 million in Q4 2025.
Analysis
Bio-Techne (TECH) Change in Cash (2009 - 2026) Analysis & Trends
Bio-Techne's Change in Cash history runs 18 years deep, the most recent figure standing at $36.9 million for Q1 2026.
- In Q1 2026, Change in Cash rose 200.17% year-over-year to $36.9 million; the TTM figure through Mar 2026 stood at $69.1 million (up 9058.81% YoY), while the FY2025 annual figure was $10.4 million, up 136.12% from the prior year.
- Change in Cash for Q1 2026 stood at $36.9 million, up from $27.9 million in the prior quarter.
- The five-year high for Change in Cash was $53.3 million in Q2 2023, with the low at -$51.0 million in Q1 2022.
- The 5-year median for Change in Cash is -$575000.0 (2022), against an average of -$119176.5.
- The sharpest annual moves came in 2023 and 2025: Change in Cash tumbled 3122.78% in 2023, then soared 379.42% in 2025.
- Bio-Techne's Change in Cash stood at -$575000.0 in 2022, then sank by 3122.78% to -$18.5 million in 2023, then soared by 46.08% to -$10.0 million in 2024, then jumped by 379.42% to $27.9 million in 2025, then soared by 32.32% to $36.9 million in 2026.
- Business Quant data shows TECH's Change in Cash at $36.9 million in Q1 2026, $27.9 million in Q4 2025, and -$17.2 million in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 649.20 Mn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | -504.60 Mn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -185.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | 374.50 Mn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 427.25 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | -2.94 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 225.59 Mn |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -37.42 Mn |
| 10 | Bio-Techne | 11.29 Bn | 11.03 Bn | 211.39 Mn | 54.89 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 54.89 Mn |
| Mar 31, 2026 | 36.94 Mn |
| Dec 31, 2025 | 27.92 Mn |
| Sep 30, 2025 | -17.22 Mn |
| Jun 30, 2025 | 21.52 Mn |
| Mar 31, 2025 | -36.88 Mn |
| Dec 31, 2024 | -9.99 Mn |
| Sep 30, 2024 | 35.75 Mn |
| Jun 30, 2024 | 11.88 Mn |
| Mar 31, 2024 | 9.78 Mn |
| Dec 31, 2023 | -18.53 Mn |
| Sep 30, 2023 | -31.91 Mn |
| Jun 30, 2023 | 53.29 Mn |
| Mar 31, 2023 | -37.40 Mn |
| Dec 31, 2022 | -575,000.00 |
| Sep 30, 2022 | -7.31 Mn |
| Jun 30, 2022 | 11.75 Mn |
| Mar 31, 2022 | -51.02 Mn |
| Dec 31, 2021 | 15.52 Mn |
| Sep 30, 2021 | -2.77 Mn |